Results 91 to 100 of about 28,258 (196)

Cumulative dose of ganciclovir (GCV) as preemptive therapy.

open access: yes, 2013
Cumulative dose of ganciclovir (GCV) as preemptive therapy.
Kana Sakamoto (454639)   +17 more
core   +1 more source

Suicide Gene Therapy By Amphiphilic Copolymer Nanocarrier for Spinal Cord Tumor

open access: yesNanomaterials, 2019
Spinal cord tumors (SCT) are uncommon neoplasms characterized by irregular growth of tissue inside the spinal cord that can result in non-mechanical back pain.
So-Jung Gwak, Jeoung Soo Lee
doaj   +1 more source

Concurrent Use of Ganciclovir and Foscarnet to Treat Cytomegalovirus Infection in AIDS Patients

open access: yes, 1993
Ten patients with AIDS and progressive cytomegalovirus disease were treated with ganciclovir and foscarnet concurrently. The patients had received ganciclovir and foscarnet monotherapy a median of 330 days before receiving combination therapy for a ...
Dieterich, Douglas T   +17 more
core   +1 more source

Successful resolution of ganciclovir-resistant cytomegalovirus (CMV) retinitis with intravitreal foscarnet in a seronegative patient of psoriasis on immunosuppressive therapy

open access: yesIndian Journal of Ophthalmology. Case Reports
We report an unusual case of intravitreal ganciclovir-resistant cytomegalovirus (CMVR) retinitis in a patient with psoriasis taking immunosuppressant medications, who responded to intravitreal foscarnet. A 37-year-old male patient presented with signs of
Debarati Dasgupta   +4 more
doaj   +1 more source

Distribution of ganciclovir in the porcine central nervous system

open access: yes
Ganciclovir is often used compassionately for encephalitis due to cytomegalovirus (CMV) and human herpes virus 6b (HHV-6b). Ganciclovir pharmacokinetic studies in the central nervous system (CNS) generally rely on single measurements in the cerebrospinal
Guldbæk, Johan Mikkel   +10 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Presumed macular toxicity of high-dose intravitreal ganciclovir

open access: yesTaiwan Journal of Ophthalmology
A 56-year-old male with bilateral cytomegalovirus retinitis was initiated on oral valganciclovir and intravitreal ganciclovir injection twice a week in first 2 weeks and once a week in subsequent weeks.
Shubhra Sweta   +5 more
doaj   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation

open access: yes, 2004
Background: Prophylactic low dose i.v. ganciclovir in patients at risk after allogeneic bone marrow transplantation (BMT) is highly effective in the prevention of cytomegalovirus (CMV) disease and infection.
Arthur, C.   +8 more
core   +1 more source

Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1

open access: yesMicrobiology Spectrum
Zoonotic infection by herpes B virus (BV) causes severe neurological disease, which in the absence of appropriate treatment can have a mortality rate of 80%.
Phu Hoang Anh Nguyen   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy